Jazz Pharmaceuticals (JAZZ) Raw Materials (2010 - 2019)

Jazz Pharmaceuticals has reported Raw Materials for 10 years, with the latest figure at $7.1 million in Q1 2019.

• For the quarter ending Q1 2019, Raw Materials changed N/A year-over-year to $7.1 million; the trailing twelve-month figure through Mar 2019 stood at $7.1 million (changed N/A YoY), and the FY2018 full-year result was $5.6 million, up 58.22% from the prior year.
• Raw Materials for Q1 2019 stood at $7.1 million, up from $5.6 million in the prior quarter.
• The five-year high for Raw Materials was $7.1 million in Q1 2019, with the low at $1.5 million in Q4 2016.
• Average Raw Materials over 5 years is $3.6 million, with a median of $2.7 million recorded in 2016.
• Year-over-year, Raw Materials slumped 40.68% in 2016 and surged 128.96% in 2017.
• Tracing JAZZ's Raw Materials over 5 years: stood at $2.6 million in 2015, then tumbled by 40.68% to $1.5 million in 2016, then jumped by 128.96% to $3.5 million in 2017, then soared by 58.22% to $5.6 million in 2018, then climbed by 27.37% to $7.1 million in 2019.
• The last three Raw Materials figures came in at $7.1 million (Q1 2019), $5.6 million (Q4 2018), and $4.2 million (Q2 2018), per Business Quant data.

Peer Comparison